Rheumatoid Arthritis. GP workshop 15 January 2011
|
|
- Edwin Watkins
- 8 years ago
- Views:
Transcription
1 Rheumatoid Arthritis GP workshop 15 January 2011
2 Case 1 A 72 year old Malay woman with RA comes for routine follow up. She feels generally unwell in the last 5 days. Appetite is fair. Her joints are fine. Her daughter accompanies her. Medications include: methotrexate 20 mg weekly hydroxychloroquine 200 mg od, prednisolone 5 mg od, enalapril 5 mg od, metformin 500 mg simvastatin 10 mg on risedronate 35 mg weekly Vit D 1000 IU od
3 Clinical examination Comfortable, in wheelchair. Afebrile, haemodynamically stable, no oral ulcers, scattered bilateral wheeze both lungs, JVP normal, no pedal oedema. Joints non tender, not swollen.
4 Thoughts Impression? Comorbidities Acute problems Chronic problems
5 Laboratory investigations Hb 9.5, WBC 2.82, Plt 326 ALT 29, AST 40, Creatinine 97,CRP 65 HbA1C 6.5% Previous visit Hb 9.0, WBC 7.69, Plt 357 ESR 96
6 Thoughts Leucopenia : possible causes Viral infection Methotrexate toxicity Pulmonary pathology LRTI
7 What next? Antibiotic- Azithromycin Beta 2 agonist inhaler Stop methotrexate Daily folic acid 5 mg See in 1 week with repeat FBC, CRP.
8 Methotrexate A typical dose regimen may be:- 7.5mg weekly increasing by 2.5mg every 6 weeks to a maximum of 25mg. Lower doses should be used in the frail elderly or if there is significant renal impairment. Regular ( weekly) folic acid supplements are thought to reduce toxicity. Cotrimoxazole or trimethoprim must be avoided in patients taking methotrexate. Excess alcohol should be avoided. Avoid Live vaccines. NSAIDs in addition to the above doses of methotrexate are not contraindicated. Annual flu vaccine should be given.
9 Withhold MTX if. and discuss with rheumatologist WBC <4.0x10^9/l Neutrophils<2.0x10^9 Platelets<150x10^9 /l >2-fold rise in AST, ALT Unexplained fall in albumin Rash or oral ulceration New or increasing dyspnoea or cough MCV>105fl investigate; if B12 or folate low start appropriate supplementation Significant deterioration in renal function reduce dose Abnormal bruising or sore throat withhold until FBC result available NB: in addition to absolute values for haematological indices a rapid fall or a consistent downward trend in any value should prompt caution and extra vigilance.
10 Case 2 A 56 year old bus driver with erosive RA comes for routine review. He tells you that he has recently had more pain in his shoulders and right elbow but is otherwise well. His medications include methotrexate 15 mg weekly, folic acid 5 mg weekly and prednisolone 5 mg daily. Routine lab monitoring: normal FBC, ALT, AST and ESR is 10.
11 Clinical examination Tenderness on palpation of shoulders and right elbow, no swelling detected. Other joints are fine, old deformities of fingers noted. Unremarkable CVS, Respiratory examination.
12 Activity of disease? Thoughts
13 Pharmacovigilance
14 Review of medications reveals that he has stopped methotrexate as his son bought medicine from Korea ginseng
15 Reassurance and the role of education Chronic disease Flares and quiescent periods- tight control Self empowerment: exercise, diet, emotional health, medications, supplements, pacing of activities Occupation Engaging family members STOP smoking
16
17 Clinical Course of RA Severity of Arthritis Years Type 1 Type 2 Type 3 Type 1 = Self-limited 5% to 20% Type 2 = Minimally progressive 5% to 20% Type 3 = Progressive 60% to 90% Pincus. Rheum Dis Clin North Am. 1995;21:619.
18
19 Uncontrolled RA is Expensive A serious, progressive condition Tremendous morbidity and functional disability Accelerated mortality Substantial work disability Costs vary directly with the severity and activity of disease
20
21 Tips in Rheumatoid Arthritis Increased risk of infection Steroids -use as bridging therapy, low dose, once daily Beware monoarticular flare think infection! Stop DMARD in the setting of infection Atypical presentation if on biologic Stress doses of steroid in infection if on long term steroid Cardiovascular burden Lymphoma risk
22 Extra-articular manifestations of RA
23 A 48 year Chinese woman presents with persistent joint pains for 3 months with fatigue. Labs show ESR 60 mm/hr, mild anaemia. What is the most important next step? A)Check rheumatoid factor to confirm diagnosis B)Prescribe a selective COX-2 inhibitor C)Give a course of high dose oral prednisolone D)Consider starting a disease-modifying anti-rheumatic agent E)Inform patient of poor prognosis due to crippling arthritis
24 Approach to polyarthritis History and Physical examination Is joint inflammation present? Will it remit or persist? Two features in history taking of diagnostic and prognostic value: morning stiffness > 60 min symptom duration > 6 wk predicts persistence > 12 wk higher spec RA diagnosis
25
Infl ectra for rheumatoid arthritis
Infl ectra for rheumatoid arthritis Some important information to get you started with your treatment This booklet is intended only for use by patients who have been prescribed Inflectra. Introduction
More informationRheumatoid Arthritis: Diagnosis, Management and Monitoring
Rheumatoid Arthritis: Diagnosis, Management and Monitoring Effective Date: September 30, 2012 Scope This guideline is intended to aid in early recognition, intervention and management of patients with
More informationSymptoms ongoing for 6/12, initially intermittent in nature.
Rheumatoid Arthritis Case Study INTRODUCTION Each student will have watched the relevant MDT member carrying out their initial assessment on the same newly diagnosed Rheumatoid Arthritis patient. Videos
More informationRHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead
RHEUMATOID ARTHRITIS Dr Bruce Kirkham Rheumatology Clinical Lead RHEUMATOID ARTHRITIS (RA) RA is a common disease: 0.8 per cent of the population RA more common in females: female to male ratio 3:1 RA
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? RA is the second most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most often appears between
More informationShared Care Guideline for the use of Leflunomide for Rheumatoid Arthritis
Shared Care Guideline for the use of Leflunomide for Rheumatoid Section 1: Agreement for transfer of prescribing to GP Please sign this form and return it to the named consultant if you are willing to
More informationDr Sarah Levy Consultant Rheumatology Croydon University Hospital
Dr Sarah Levy Consultant Rheumatology Croydon University Hospital Contents Definition/ epidemiology Diagnosis Importance of early diagnosis/ treatment Guidelines Evidence based treatment protocol Current
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationabc Trust Guideline for Use of Oral Methotrexate, Shared Care Guideline for Adults
Trust Guideline for abc Use of Oral Methotrexate, Shared Care Guideline for Adults A guideline recommended for use In: East and North Herts NHS Trust East and North Herts PCT By: Consultants in East and
More informationInformation on Rheumatoid Arthritis
Information on Rheumatoid Arthritis Table of Contents About Rheumatoid Arthritis 1 Definition 1 Signs and symptoms 1 Causes 1 Risk factors 1 Test and diagnosis 2 Treatment options 2 Lifestyle 3 References
More informationRheumatoid Arthritis
Rheumatoid Arthritis Carole Callaghan Principal Pharmacist NHS Lothian Aim To update pharmacists on the current management of rheumatoid arthritis and explore ways to implement pharmaceutical care for
More informationUnderstanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result
More informationRheumatoid Arthritis monitoring of DMARDs
www.bpac.org.nz keyword: DMARDS Rheumatoid Arthritis monitoring of DMARDs Key reviewers: Professor John Highton, Head of Section, Department of Medical and Surgical Sciences, Dunedin School of Medicine,
More informationCurrent Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists
Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists 1. Which of the following matches of biologic targets that contribute to rheumatoid arthritis (RA) and
More informationRheumatoid Arthritis
What is Rheumatoid Arthritis? Rheumatoid Arthritis (RA) is a chronic and systemic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Though joints
More informationTrust Guideline. for. Shared Care Guidelines for the Use of Leflunomide (Arava )
A guideline recommended for use Trust Guideline for Shared Care Guidelines for the Use of Leflunomide (Arava ) In: By: For: East and North Herts NHS Trust (ENHT) East and North Herts PCT/ENHCCG Consultants
More information(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society
Arthritis 101 (Intro to Arthritis with a Focus on Rheumatoid Arthritis) by Cari Taylor by Cari Taylor Manager of Education & Services for the Vancouver Island Region of The Arthritis Society What You Will
More informationRheumatoid Arthritis. What is rheumatoid arthritis? Understanding joints. What causes rheumatoid arthritis?
Page 1 of 6 Rheumatoid Arthritis Rheumatoid arthritis causes inflammation, pain, and swelling of joints. In time, affected joints typically become damaged. The severity can vary from mild to severe. Treatments
More informationLEFLUNOMIDE (Adults)
Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active
More informationRheumatoid Arthritis. Disease RA Final.indd 2 15. 6. 10. 11:23
Rheumatoid Arthritis Disease RA Final.indd 2 15. 6. 10. 11:23 Understanding what to expect can help you prepare for your transition into treatment. Rheumatoid Arthritis What You Need To Know About Rheumatoid
More informationMETHOTREXATE Rheumatoid arthritis, Psoriasis, Crohn s Disease & Ulcerative Colitis DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AND FILED IN NOTES
NHS ONEL and BHRuT NHS Trust Shared Care Guidelines METHOTREXATE Rheumatoid arthritis, Psoriasis, Crohn s Disease & Ulcerative Colitis DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AND FILED IN NOTES
More informationRheumatoid Arthritis. Outline. Treatment Goal 4/10/2013. Clinical evaluation New treatment options Future research Discussion
Rheumatoid Arthritis Robert L. Talbert, Pharm.D., FCCP, BCPS University of Texas at Austin College of Pharmacy University of Texas Health Science Center at San Antonio Outline Clinical evaluation New treatment
More informationPsoriasis and Psoriatic Arthritis Alliance
Psoriasis and Psoriatic Arthritis Alliance A principal source of information on psoriasis and psoriatic arthritis ) Treatments for Psoriatic Arthritis overview Although psoriatic arthritis is a chronic
More informationRheumatoid Arthritis
Rheumatoid Arthritis While rheumatoid arthritis (RA) has long been feared as one of the most disabling types of arthritis, the outlook has dramatically improved for many newly diagnosed patients. Certainly
More informationTAKING CARE OF YOUR RHEUMATOID ARTHRITIS
TAKING CARE OF YOUR RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS (RA) FAST FACTS What is Rheumatoid Arthritis? Rheumatoid arthritis (RA) is a chronic disease that can affect your ability to function and be
More informationShared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
More informationPsoriatic Arthritis www.arthritis.org.nz
Psoriatic Arthritis www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Psoriatic arthritis usually appears in people between the ages of 30 to 50.
More informationMedicines for Psoriatic Arthritis. A Review of the Research for Adults
Medicines for Psoriatic Arthritis A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have psoriatic (pronounced
More informationA LTCI Approach to Managing Rheumatoid Arthritis
A LTCI Approach to Managing Rheumatoid Arthritis A bit of Science, a bit of Art, a lot of Perseverance... Stephen K. Holland, MD Senior Vice President & Medical Director Long Term Care Group, Inc. Long
More informationEarly identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway
Early identification and treatment - the Norwegian perspective Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway Oslo Rheumatoid Arthritis Registry (ORAR) Very early Arthritis Clinic
More informationThe management of rheumatoid arthritis
Medical management of rheumatoid arthritis Peter Jones Correspondence to: peter.jones@qehealth.co.nz The management of rheumatoid arthritis has changed in the last 10 years. Back then, a patient who awoke
More informationCOPD What Is It? Why is it so hard to catch my breath? What does COPD feel like? What causes COPD? What is an exacerbation (ig-zas-er-bay-shun)?
Attitudes and Beliefs 4 COPD What Is It? Why is it so hard to catch my breath? COPD is a disease that damages the lungs. In a healthy lung, the airways are open and the air sacs fill up with air. Then
More informationMETHOTREXATE TREATMENT
METHOTREXATE TREATMENT This leaflet has been prepared to support information given to you as part of your discussions with the doctor, nurse or pharmacist before you start treatment with oral methotrexate.
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? Rheumatoid arthritis (RA) is the third most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most
More informationMethotrexate treatment
Methotrexate treatment Oral methotrexate pre-treatment patient information leaflet This leaflet has been prepared to support information given to you as part of your discussions with the doctor, nurse
More informationIt is most common between the ages of 40 and 70, but can affect people of any age.
Rheumatoid arthritis Introduction Rheumatoid arthritis is a condition that causes pain and swelling in the joints. Hands, feet and wrists are commonly affected, but it can also damage other parts of the
More information3 Rd Year Medical Student Lecture Series. Rheumatology Cases. N. Lawrence Edwards, MD
3 Rd Year Medical Student Lecture Series Rheumatology Cases N. Lawrence Edwards, MD Case Study #1 32 yo WF accountant with 6 months of bilat finger and wrist pain and swelling. Morning stiffness involving
More informationRheumatoid Arthritis:
Rheumatoid Arthritis Update 2014 Mark Hulsey, MD FACR Rheumatoid Arthritis Key Features Symptoms >6 weeks duration Often lasts the remainder of the patient s life Inflammatory synovitis Palpable synovial
More informationRheumatology. Rheumatoid Arthritis
Rheumatology Rheumatoid Arthritis The Rheumatology service specialises in the diagnosis and treatment of diseases affecting the musculoskeletal system. Other than providing inpatient and outpatient consultation,
More informationProfile of Psoriatic Arthritis: What to expect as a typical patient Dr Deepak Jadon
Profile of Psoriatic Arthritis: What to expect as a typical patient Dr Deepak Jadon Rheumatology Specialist Registrar & PhD Research Fellow 2 Overview Back ground on psoriatic arthritis (PsA) Epidemiology
More informationGuideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
More informationRheumatoid Arthritis: Constantly Evolving Treatment Approaches
Rheumatoid Arthritis: Constantly Evolving Treatment Approaches Jody Garry, Pharm.D. Primary Care Pharmacy Resident VA Medical Center - Iowa City Presentation Overview Pathophysiology & epidemiology Diagnostic
More informationPolymyalgia Rheumatica www.arthritis.org.nz
Polymyalgia Rheumatica www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Polymyalgia rheumatica is a common rheumatic condition. It affects more women
More informationPatient Information Leaflet
Patient Information Leaflet METHOTREXATE We hope this fact sheet will provide you with some information about Methotrexate and answer some of the questions you may have. Methotrexate is available in tablet
More informationRheumatoid Arthritis Medicines. A Guide for Adults
Rheumatoid Arthritis Medicines A Guide for Adults Fast Facts Medicines for rheumatoid arthritis (RA) can slow down the disease and reduce damage to joints. They can relieve pain and make it easier to do
More informationThe new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationRheumatoid Arthritis Information
Rheumatoid Arthritis Information Definition Rheumatoid arthritis (RA) is a long-term disease that leads to inflammation of the joints and surrounding tissues. It can also affect other organs. Alternative
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) September 2014 Review date: September 2017 Bulletin 203: Tocilizumab (subcutaneous) in combination with methotrexate or as monotherapy for the treatment
More information2010 QARR QUICK REFERENCE GUIDE Adults
2010 QARR QUICK REFERENCE GUIDE Adults ADULT MEASURES (19 through 64 years) GUIDELINE HEDIS COMPLIANT CPT/ICD9 CODES DOCUMENTATION TIPS Well Care Access to Ambulatory Care Ensure a preventive or other
More informationDISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY
ORIGINAL ARTICLES DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY Teodora Serban 1,2, Iulia Satulu 2, Oana Vutcanu 2, Mihaela Milicescu 1,2, Carina Mihai 1,2, Mihai Bojinca 1,2, Victor
More informationRheumatoid Arthritis. Nicole Klett,, M.D.
Rheumatoid Arthritis Nicole Klett,, M.D. Rheumatoid Arthritis Systemic Chronic Inflammatory Primarily targets the synovium of diarthrodial joints Etiology likely combination genetic and environmental Diarthrodial
More informationLeflunomide Leflunomide
Drug information Leflunomide Leflunomide This leaflet provides information on leflunomide and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets
More informationLupus in Children and Teenagers. Arielle Hay, MD Pediatric Rheumatologist Nicklaus Children s Hospital
Lupus in Children and Teenagers Arielle Hay, MD Pediatric Rheumatologist Nicklaus Children s Hospital Systemic Lupus Erythematosus (SLE) Chronic Illness What is lupus? Autoimmune Multisystem Antinuclear
More informationJanuary 2007. Results Case study 45: DMARDs in rheumatoid arthritis
Results Case study 45: DMARDs in rheumatoid arthritis January 2007 NPS is an independent, non-profit organisation for Quality Use of Medicines, funded by the Australian Government Department of Health
More informationGuidelines for the Pharmaceutical Management of Rheumatoid Arthritis Swedish Society of Rheumatology, April 14, 2011
Guidelines for the Pharmaceutical Management of Rheumatoid Arthritis Swedish Society of Rheumatology, April 14, 2011 Working party: Eva Baecklund, Helena Forsblad d Elia, Carl Turesson Background Our purpose
More informationTreatment of Severe Rheumatoid Arthritis
Treatment of Severe Rheumatoid Arthritis Zhanguo Li Department of Rheumatology and Immunology, People s Hospital Beijing University Medical School, China Contents Background Challenges Treatment strategies
More informationMaster Thesis in Medicine
RISK OF INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB IN CLINICAL PRACTICE Master Thesis in Medicine Joyce Åkerlund Supervisor: Catharina Lindholm, MD, PhD, Associate Professor Department
More informationThere is a risk of renal impairment in dehydrated children and adolescents.
PACKAGE LEAFLET: INFORMATION FOR THE USER MELFEN 200mg FILM-COATED TABLETS MELFEN 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking this medicine because it
More informationDisease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment
A WHITE PAPER BY Disease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment Increased adherence rates deliver improved outcomes for patients FALL 2010 The Benefits of DTM for Rheumatoid Arthritis
More informationABOUT RHEUMATOID ARTHRITIS
MEDIA BACKGROUNDER ABOUT RHEUMATOID ARTHRITIS Rheumatoid arthritis (RA) is a type of arthritis (chronic inflammatory polyarthritis) that typically affects hands and feet, although any joint in the body
More informationCLL. Handheld record. Stockport NHS foundation trust
CLL 2015 Handheld record Contains- Patient information booklet, details of haematology clinic assessment and ongoing clinical assessment at GP surgery Stockport NHS foundation trust You have been diagnosed
More informationEMEA PUBLIC STATEMENT ON LEFLUNOMIDE (ARAVA) - SEVERE AND SERIOUS HEPATIC REACTIONS -
The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 12 March 2001 Doc. Ref: EMEA/H/5611/01/en EMEA PUBLIC STATEMENT ON LEFLUNOMIDE
More informationRivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)
Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep
More informationRheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly
More informationGENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan
GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan SELF ASSESSMENT FORM FOR STUDY SUBJECTS AND CONTROLS Accession Number (will be filled in by lab)
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure
More informationCOPD - Education for Patients and Carers Integrated Care Pathway
Patient NHS COPD - Education for Patients and Carers Integrated Care Pathway Date ICP completed:. Is the patient following another Integrated Care Pathway[s].. / If yes, record which other Integrated Care
More informationAssessment of pulmonary function in rheumatoid arthritis patients attending Rheumatology Clinics in Nairobi
1 College of Health Sciences, University of Nairobi, Nairobi, Kenya 2 Kenyatta National Hospital, Nairobi, Kenya 3 KAPTLD, Nairobi, Kenya Corresponding author: Dr. I. Biomdo, Department of Internal Medicine,
More informationRheumatoid Arthritis: Key Features
Rheumatoid Arthritis: Key Features Symptoms >6 weeks duration Often lasts the remainder of the patient s life Inflammatory synovitis Palpable synovial swelling Morning stiffness >1 hour, fatigue Symmetrical
More informationArthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis
Arthritis and Rheumatology Clinics of Kansas Patient Education Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis Introduction: For as long as scientists have studied rheumatic disease,
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationRheumatoid Arthritis
Rheumatoid Arthritis His MD called it Radical Rheumatoid Arthritis meaning his case was very aggressive and would most likely leave him crippled. In just 3 months- Decreased Inflammation/Pain Increased
More informationArthritis and Rheumatology. Antoni Chan MBChB, FRCP, PhD Consultant Rheumatologist Royal Berkshire NHS Foundation Trust
Antoni Chan MBChB, FRCP, PhD Consultant Rheumatologist Royal Berkshire NHS Foundation Trust Rheumatology Investigation, Diagnosis, Treatment The challenge 8 billion a year in cost 700,000 people suffering
More informationPage 1 of 15 Origination Date: 09/14 Revision Date(s): 10/2015, 02/2016 Developed By: Medical Criteria Committee 10/28/2015
Moda Health Plan, Inc. Medical Necessity Criteria Subject: Actemra (tocilizumab) Page 1 of 15 Origination Date: 09/14 Revision Date(s): 10/2015, 02/2016 Developed By: Medical Criteria Committee 10/28/2015
More informationClinical guideline for the diagnosis and management of early rheumatoid arthritis
Clinical guideline for the diagnosis and management of early rheumatoid arthritis August 2009 The Royal Australian College of General Practitioners, 1 Palmerston Crescent, South Melbourne, Vic 3205 Australia
More informationOnce the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.
HealthExchange Points For Your Joints An Arthritis Talk Howard Epstein, MD Orthopaedic & Rheumatologic Institute Rheumatic & Immunologic Disease Cleveland Clinic Beachwood Family Health & Surgery Center
More informationRheumatoid Arthritis. How are joints in the body designed?
Rheumatoid Arthritis How are joints in the body designed? There are more than 100 joints that connect the body s 206 bones. These joints allow us to move the way we do when we walk to work, throw a ball
More informationPneumonia Education and Discharge Instructions
Pneumonia Education and Discharge Instructions Pneumonia Education and Discharge Instructions Definition: Pneumonia is an infection of the lungs. Many different organisms can cause it, including bacteria,
More informationto Part of Dossier: Name of Active Ingredient: Title of Study: Quality of life study with adalimumab in rheumatoid arthritis. ESCALAR.
2.0 Synopsis Abbott Laboratories Name of Study Drug: Individual Study Table Referring to Part of Dossier: Adalimumab (HUMIRA) (For National Authority Use Only) Name of Active Ingredient: Adalimumab Title
More informationPOAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationArthritis www.patientedu.org
written by Harvard Medical School Arthritis www.patientedu.org Arthritis is the most common chronic disease in the world, and it s the leading cause of disability in the United States. There are more than
More informationPsoriatic Arthritis. What is psoriatic arthritis? Understanding joints. Who gets psoriatic arthritis? Page 1 of 5
Page 1 of 5 Psoriatic Arthritis Psoriatic arthritis causes inflammation, pain, and swelling of joints in some people who have psoriasis. Other parts of the body may also be affected. For example, in many
More informationRheumatoid Arthritis: New tests, new treatments and. Christine H Jones MD Assistant Professor of Medicine UVM/FAHC
Rheumatoid Arthritis: New tests, new treatments and new perspectives Christine H Jones MD Assistant Professor of Medicine UVM/FAHC Objectives Discuss physical and laboratory findings in rheumatoid arthritis
More informationRecommendations for Early RA Patients
SUPPLEMENTARY APPENDIX 5: Executive summary of recommendations for patients with early RA, established RA, and high-risk comorbidities Recommendations for Early RA Patients We strongly recommend using
More informationTeriflunomide (Aubagio) 14mg once daily tablet
Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision
More informationMethotrexate Dose For Juvenile Rheumatoid Arthritis
Methotrexate Dose For Juvenile Rheumatoid Arthritis should i take methotrexate for my ra methotrexate 50 mg/ml methotrexate sodium 2.5mg tablets what is the usual dosage of methotrexate for ra methotrexate
More informationArthritis in Children: Juvenile Rheumatoid Arthritis By Kerry V. Cooke
Reading Comprehension Read the following essay on juvenile rheumatoid arthritis. Then use the information in the text to answer the questions that follow. Arthritis in Children: Juvenile Rheumatoid Arthritis
More informationMedicines for Rheumatoid. Arthritis. A Review of the Research for Adults
Medicines for Rheumatoid Arthritis A Review of the Research for Adults Is This Information Right for Me? Yes, this summary is for you if: Your doctor* has told you that you have rheumatoid (pronounced
More informationMethotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Brochure More information from http://www.researchandmarkets.com/reports/3128342/ Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Description: Methotrexate (Rheumatoid Arthritis)
More informationCOPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
More informationAm I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms
Am I likely to develop Rheumatoid rheumatoid Arthritis? arthritis? A guide for people with joint symptoms At a glance Rheumatoid arthritis (RA) is a common disease that causes painful and swollen joints,
More informationA Survey of Barriers to Treatment Access in Rheumatoid Arthritis. Country Annex Report: UK
A Survey of Barriers to Treatment Access in Rheumatoid Arthritis Country Annex Report: UK October 2009 1 Interviews In the UK, five rheumatologists and one patient representative were interviewed. The
More informationStandard of care for RA in SA 2013
Standard of care for RA in SA 2013 Background Rheumatoid arthritis (RA) is a chronic inflammatory disease, which if treated inadequately leads to irreversible joint damage, resulting in deformities, disability
More informationHow To Choose A Biologic Drug
North Carolina Rheumatology Association Position Statements I. Biologic Agents A. Appropriate delivery, handling, storage and administration of biologic agents B. Indications for biologic agents II. III.
More informationFinding out your child has Juvenile Idiopathic Arthritis (JIA)
Finding out your child has Juvenile Idiopathic Arthritis (JIA) Information for parents, families and carers Jetstar Flying Start Ambassador Steve Price with Tamsin Taylor and Jennifer McNaughton Did you
More informationRheumatoid arthritis: diagnosis, treatment and prognosis. Dr David D Cruz MD FRCP Consultant Rheumatologist
Rheumatoid arthritis: diagnosis, treatment and prognosis Dr David D Cruz MD FRCP Consultant Rheumatologist The Louise Coote Lupus Unit St Thomas Hospital London AMUS meeting London 7 th March 2012 Disclosures
More informationCalm before the Storm: Cholesterol Pericarditis in Rheumatoid Arthritis
Calm before the Storm: Cholesterol Pericarditis in Rheumatoid Arthritis Nadil Zeiadin MD, Matthew Woo MD, Gursimran Chandokee MD Department of Internal Medicine Queen s University Kingston, ON Learning
More informationCyclosporine (Neoral)
Cyclosporine (Neoral) How does it work? Cyclosporine is used to lower the body s immune system. Your immune system, which normally helps to protect your body from infection and disease, is out of order.
More information